TWD
BSX icon

True Wealth Design’s Boston Scientific BSX Stock Holding History

True Wealth Design’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
2,891
+1,536
+113% +$83.4K 0.03% 200
2026
Q1 		$85K Buy
1,355
+1,164
+609% +$93.1K 0.02% 253
2025
Q4 		$18.2K Sell
191
-222
-54% -$21.8K 0.01% 646
2025
Q3 		$40.3K Buy
413
+202
+96% +$20.9K 0.01% 379
2025
Q2 		$22.6K Buy
211
+39
+23% +$3.95K 0.01% 355
2025
Q1 		$17.3K Buy
172
+130
+310% +$13.1K 0.01% 367
2024
Q4 		$3.71K Buy
42
+19
+83% +$1.67K ﹤0.01% 595
2024
Q3 		$1.93K Hold
23
– – ﹤0.01% 804
2024
Q2 		$1.77K Buy
23
+6
+35% +$439 ﹤0.01% 381
2024
Q1 		$1.17K Buy
17
+7
+70% +$450 ﹤0.01% 431
2023
Q4 		$579 Hold
10
– – ﹤0.01% 441
2023
Q3 		$528 Hold
10
– – ﹤0.01% 418
2023
Q2 		$541 Hold
10
– – ﹤0.01% 422
2023
Q1 		$501 Hold
10
– – ﹤0.01% 523
2022
Q4 		$463 Buy
+10
New +$433 ﹤0.01% 474

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

True Wealth Design's BSX Position: Q2 2026 in Review

True Wealth Design increased its Boston Scientific (BSX) stake by 113% in Q2 2026, buying an estimated $83.4K and bringing the position to 2,891 shares worth $123K. The position accounts for 0.03% of the portfolio, ranked #200.

True Wealth Design first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • True Wealth Design held 2,891 shares of Boston Scientific worth $123K as of Q2 2026.
  • True Wealth Design bought 1,536 Boston Scientific shares in Q2 2026, an estimated $83.4K.
  • Boston Scientific made up 0.03% of True Wealth Design's portfolio in Q2 2026, its #200 holding.
  • True Wealth Design first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.